Patent intelligence · US
US 8263762
Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as A2AR agonists
Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as A2AR agonists
Patent details — US 8263762
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 11, 2012
- Expiration
- Sep 6, 2032
- Applicant
- Dogwood Pharmaceuticals, Inc.
- Claims
- 33
- CPC classes
- A61P, A61P13/12, A61P17/00, A61P17/02
Quick answer
US 8263762 (Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as A2AR agonists) is held by Dogwood Pharmaceuticals, Inc.. Status: granted. Granted Sep 11, 2012. Expires Sep 6, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Dogwood Pharmaceuticals, Inc.
- Grant date
- Expiration
- Claims
- 33
- CPC classes
- A61P, A61P13/12, A61P17/00, A61P17/02, A61P19/06, A61P27/02
More from Dogwood Pharmaceuticals, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 9446021
Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof
granted -
US 9120754
Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof
granted -
US 8349848
Pyrrolo[3,2-D]pyrimidines that are selective antagonists of A2B adenosine receptors
granted -
US 8293720
Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
granted -
US 8258142
Substituted 8-[6-amino-3-pyridyl]xanthines
granted -
US 8252767
Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
granted
Frequently asked questions
What is US patent 8263762?
US 8263762 (Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as A2AR agonists) is held by Dogwood Pharmaceuticals, Inc.. Status: granted. Granted Sep 11, 2012. Expires Sep 6, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8263762?
Dogwood Pharmaceuticals, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 7 pharmaceutical patents for this assignee.
When does US 8263762 expire?
Our index shows an expiration date of Sep 6, 2032 (6 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.